abstract: Patient Advocacy Organizations and Corporate Relationships -- Weinberg 101 (4): 582 -- American Journal of Public Health

April 2011, Vol 101, No. 4 | American Journal of Public Health 582-583
© 2011 American Public Health Association
DOI: 10.2105/AJPH.2011.300087

LETTERS

Patient Advocacy Organizations and Corporate Relationships
Myrl Weinberg, MA
Myrl Weinberg is president of the National Health Council, Washington, DC.
Correspondence: Correspondence should be sent to Myrl Weinberg, National Health Council, 1730 M Street, NW, Suite 500, Washington, DC 20036-4561 (e-mail: mweinberg@nhcouncil.org). Reprints can be ordered at http://www.ajph.org by clicking the "Reprints/Eprints" link.

	Because this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

Since its creation in 1920, the National Health Council (NHC) has been dedicated to the values of integrity, transparency, and honesty. It is crucial that the patients we represent, the public, and the policy makers receive accurate information about how patient advocacy organizations conduct their relationships with corporate America.
The NHC agrees with Rothman et al. about the need for transparency.¹ For this reason, any patient advocacy organization that wishes to join or retain its membership in the NHC must disclose funding received from corporations and present the information in an easily accessible manner within 6 months of the close . . . [Full Text]